North Dakota State Investment Board Invests $1.12 Million in Kenvue Inc. $KVUE

North Dakota State Investment Board bought a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 65,152 shares of the company’s stock, valued at approximately $1,124,000.

Several other hedge funds have also modified their holdings of KVUE. Van ECK Associates Corp boosted its stake in shares of Kenvue by 101.3% during the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after acquiring an additional 9,240,434 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Kenvue by 22.4% during the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after acquiring an additional 6,781,640 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of Kenvue by 156.2% during the 4th quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock worth $146,475,000 after acquiring an additional 5,177,404 shares in the last quarter. Mondrian Investment Partners LTD purchased a new stake in shares of Kenvue during the 3rd quarter worth about $79,269,000. Finally, Alliancebernstein L.P. lifted its stake in Kenvue by 115.9% in the 2nd quarter. Alliancebernstein L.P. now owns 6,438,473 shares of the company’s stock valued at $134,757,000 after buying an additional 3,456,204 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on KVUE. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Citigroup decreased their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Insider Activity at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.59% of the stock is currently owned by company insiders.

Kenvue Stock Up 1.0%

Shares of NYSE KVUE opened at $17.33 on Thursday. The company has a 50 day simple moving average of $17.42 and a 200-day simple moving average of $17.39. The company has a market capitalization of $33.27 billion, a P/E ratio of 20.38, a P/E/G ratio of 1.30 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $24.35.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business’s revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.24 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. Kenvue’s payout ratio is 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.